Kay E. Gurley
- Molecular Biology top 5%
- Oncology top 2%
- Immunology top 5%
- Cancer Research top 5%
- Genetics top 10%
- Co-authors
- Christopher J. KempBruce M. HallMatthew L. FeroJames M. RobertsNICHOLAS W. PEARCESusan E. DorschRussell MoserKaren S. Kelly‐Spratt
- Topics
- Cancer-related Molecular Pathways (21 papers)DNA Repair Mechanisms (8 papers)Cancer Research and Treatments (8 papers)
- Cited by
- TransplantationOncologyImmunology
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Kay E. Gurley
53 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.9k
- Oncology 1.2k
- Immunology 799
- Cancer Research 464
- Genetics 260
Countries citing papers authored by Kay E. Gurley
This map shows the geographic impact of Kay E. Gurley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay E. Gurley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay E. Gurley more than expected).
Fields of papers citing papers by Kay E. Gurley
This network shows the impact of papers produced by Kay E. Gurley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay E. Gurley. The network helps show where Kay E. Gurley may publish in the future.
Co-authorship network of co-authors of Kay E. Gurley
This figure shows the co-authorship network connecting the top 25 collaborators of Kay E. Gurley. A scholar is included among the top collaborators of Kay E. Gurley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay E. Gurley. Kay E. Gurley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 22 | |
| 4 | 19 | |
| 5 | 15 | |
| 6 | 66 | |
| 7 | 139 | |
| 8 | 13 | |
| 9 | 43 | |
| 10 | 35 | |
| 11 | 37 | |
| 12 | 32 | |
| 13 | 69 | |
| 14 | 62 | |
| 15 | 21 | |
| 16 | 37 | |
| 17 | 119 | |
| 18 | 29 | |
| 19 | 27 | |
| 20 | 135 |
About Kay E. Gurley
Kay E. Gurley is a scholar working on Transplantation, Biotechnology and Oncology, having authored 53 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (21 papers), DNA Repair Mechanisms (8 papers) and Cancer Research and Treatments (8 papers). The work is most often cited by research in Transplantation (179 citations), Oncology (1.2k citations) and Immunology (799 citations). Kay E. Gurley has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Christopher J. Kemp, Bruce M. Hall, Matthew L. Fero, James M. Roberts, NICHOLAS W. PEARCE, Susan E. Dorsch, Russell Moser, Karen S. Kelly‐Spratt, Margaret Jelbart and Denny Liggitt. Their work appears in journals such as Nature, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.